| 51 |
32275773 | P-Glycoprotein Inhibition Exacerbates Paclitaxel Neurotoxicity in Neurons and Patients With Cancer. | 2020 Sep |
5 |
| 52 |
32353410 | FNDC5 promotes paclitaxel sensitivity of non-small cell lung cancers via inhibiting MDR1. | 2020 Aug |
2 |
| 53 |
32401925 | Treatment with β-elemene combined with paclitaxel inhibits growth, migration, and invasion and induces apoptosis of ovarian cancer cells by activation of STAT-NF-κB pathway. | 2020 |
1 |
| 54 |
32457290 | Decreased expression of FBXW7 by ERK1/2 activation in drug-resistant cancer cells confers transcriptional activation of MDR1 by suppression of ubiquitin degradation of HSF1. | 2020 May 26 |
1 |
| 55 |
32489129 | Hyaluronic acid reduction-sensitive polymeric micelles achieving co-delivery of tumor-targeting paclitaxel/apatinib effectively reverse cancer multidrug resistance. | 2020 Dec |
1 |
| 56 |
32497533 | The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells. | 2020 Aug 15 |
2 |
| 57 |
32536602 | Chemotherapy-Induced IL8 Upregulates MDR1/ABCB1 in Tumor Blood Vessels and Results in Unfavorable Outcome. | 2020 Jul 15 |
2 |
| 58 |
32564116 | ABCB1 and ERCC1 gene polymorphisms are associated with nephro- and hepatotoxicity to carboplatin/paclitaxel-based chemotherapy in patients with gynecologic cancers. | 2020 Oct |
3 |
| 59 |
32569926 | Synthesis and biological evaluation of thiophenylbenzofuran derivatives as potential P-glycoprotein inhibitors. | 2020 Sep 1 |
2 |
| 60 |
32643224 | Carrier-Free Delivery of Precise Drug-Chemogene Conjugates for Synergistic Treatment of Drug-Resistant Cancer. | 2020 Oct 5 |
2 |
| 61 |
32707710 | The Multidrug Resistance-Reversing Activity of a Novel Antimicrobial Peptide. | 2020 Jul 19 |
4 |
| 62 |
32872293 | Metformin Derivative HL156A Reverses Multidrug Resistance by Inhibiting HOXC6/ERK1/2 Signaling in Multidrug-Resistant Human Cancer Cells. | 2020 Aug 28 |
1 |
| 63 |
32887626 | Dual drug-loaded nano-platform for targeted cancer therapy: toward clinical therapeutic efficacy of multifunctionality. | 2020 Sep 4 |
2 |
| 64 |
32903706 | Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug Resistance. | 2020 |
1 |
| 65 |
32984343 | Bruton's Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells. | 2020 |
2 |
| 66 |
33050126 | Homotype-Targeted Biogenic Nanoparticles to Kill Multidrug-Resistant Cancer Cells. | 2020 Oct 9 |
2 |
| 67 |
33163405 | Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 Transporter. | 2020 |
1 |
| 68 |
33207738 | Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance. | 2020 Nov 16 |
2 |
| 69 |
33280384 | Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-a]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators. | 2020 Dec 24 |
2 |
| 70 |
29956630 | Formulation, Pharmacokinetic Evaluation and Cytotoxicity of an Enhanced- penetration Paclitaxel Nanosuspension. | 2019 |
2 |
| 71 |
30230544 | Chloride channel-3 mediates multidrug resistance of cancer by upregulating P-glycoprotein expression. | 2019 May |
1 |
| 72 |
30317630 | Androgen receptor transcriptional activity and chromatin modifications on the ABCB1/MDR gene are critical for taxol resistance in ovarian cancer cells. | 2019 Jun |
6 |
| 73 |
30367323 | Chemotherapy in pregnancy: exploratory study of the effects of paclitaxel on the expression of placental drug transporters. | 2019 Oct |
4 |
| 74 |
30391357 | Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo. | 2019 Feb 1 |
2 |
| 75 |
30711936 | AS602801 Sensitizes Ovarian Cancer Stem Cells to Paclitaxel by Down-regulating MDR1. | 2019 Feb |
3 |
| 76 |
30765569 | Structural insight into substrate and inhibitor discrimination by human P-glycoprotein. | 2019 Feb 15 |
2 |
| 77 |
30790579 | Inhibitory effects of flavonoids on P-glycoprotein in vitro and in vivo: Food/herb-drug interactions and structure-activity relationships. | 2019 Apr 15 |
2 |
| 78 |
30894541 | Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer. | 2019 Mar 20 |
1 |
| 79 |
30911326 | Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation. | 2019 |
2 |
| 80 |
31103263 | Intracellular Doppler Spectroscopy detects altered drug response in SKOV3 tumor spheroids with silenced or inhibited P-glycoprotein. | 2019 Jul 5 |
3 |
| 81 |
31106148 | Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer Cells. | 2019 |
1 |
| 82 |
31123858 | Impact of gene polymorphisms on the systemic toxicity to paclitaxel/carboplatin chemotherapy for treatment of gynecologic cancers. | 2019 Aug |
1 |
| 83 |
31127007 | Evidence for the Interaction of A3 Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1). | 2019 Aug |
2 |
| 84 |
31156720 | Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer. | 2019 |
1 |
| 85 |
31190887 | Mitochondria P-glycoprotein confers paclitaxel resistance on ovarian cancer cells. | 2019 |
2 |
| 86 |
31196356 | Nano-Porous Silica Aerogels as Promising Biomaterials for Oral Drug Delivery of Paclitaxel. | 2019 Jul 1 |
4 |
| 87 |
31248184 | A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor. | 2019 Jun 19 |
1 |
| 88 |
31336860 | Gliotoxin Enhances Autophagic Cell Death via the DAPK1-TAp63 Signaling Pathway in Paclitaxel-Resistant Ovarian Cancer Cells. | 2019 Jul 12 |
1 |
| 89 |
31350703 | Involvement of the MDR1 gene and glycolipids in anticancer drug-resistance of human ovarian carcinoma-derived cells. | 2019 Oct |
4 |
| 90 |
31404980 | Deciphering Hydrodynamic and Drug-Resistant Behaviors of Metastatic EMT Breast Cancer Cells Moving in a Constricted Microcapillary. | 2019 Aug 9 |
1 |
| 91 |
31467112 | Breast Cancer Risk-Associated SNPs in the mTOR Promoter Form De Novo KLF5- and ZEB1-Binding Sites that Influence the Cellular Response to Paclitaxel. | 2019 Nov |
3 |
| 92 |
31476282 | Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistance. | 2019 Nov 15 |
1 |
| 93 |
31536779 | In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆. | 2019 Dec 1 |
1 |
| 94 |
31570440 | Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter. | 2019 Oct |
4 |
| 95 |
31571407 | ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane-based chemotherapy. | 2019 Nov |
1 |
| 96 |
31801248 | Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression. | 2019 Nov 30 |
1 |
| 97 |
31867270 | Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness. | 2019 |
1 |
| 98 |
28771725 | TLR4 and NFκB signaling is critical for taxol resistance in ovarian carcinoma cells. | 2018 Mar |
6 |
| 99 |
29208281 | Overcoming STC2 mediated drug resistance through drug and gene co-delivery by PHB-PDMAEMA cationic polyester in liver cancer cells. | 2018 Feb 1 |
2 |
| 100 |
29251928 | Comprehensive Synthesis of Amino Acid-Derived Thiazole Peptidomimetic Analogues to Understand the Enigmatic Drug/Substrate-Binding Site of P-Glycoprotein. | 2018 Feb 8 |
2 |